Clinical Trial to Evaluate the Symptoms in Symptomatic Contact Lens Wearers Following Application of Intranasal Tear Neurostimulator Versus Control
NCT03325673
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndromes
Interventions
DEVICE:
TrueTear
DEVICE:
TrueTear Sham Control
Sponsor
Allergan